Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 14 of 14 entries
View as:

VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT01241760 Org: User:
Start: 12/31/10 End: 11/30/12 Due: 11/30/13

TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).

Phase: N/A Priority: Normal
NCT ID: NCT00449644 Org: User:
Start: 06/30/07 End: 10/31/12 Due: 10/31/13

A Study to Assess the Relative Bioavailability of TMC207 Following Single-Dose Administrations of Two Pediatric Formulations in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT01803373 Org: User:
Start: 04/30/13 End: 08/31/13 Due: 08/31/14

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT02114151 Org: User:
Start: 04/30/14 End: 04/30/15 Due: 04/30/16

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT02114177 Org: User:
Start: 04/30/14 End: 04/30/15 Due: 04/30/16

To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.

Phase: N/A Priority: Normal
NCT ID: NCT00910871 Org: User:
Start: 09/30/09 End: 01/31/13 Due: 01/31/14

A Study to Evaluate the Pharmacokinetic Effects of Different Storage Conditions for a Long-Acting Nanosuspension of Rilpivirine on Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT02547870 Org: User:
Start: 08/14/15 End: 04/26/16 Due: 04/26/17

VX-950-TiDP24-C219: A Roll Over Trial for Patients in the Control Group of the C216 Study Who Received Telaprevir Placebo

Phase: N/A Priority: Normal
NCT ID: NCT01054573 Org: User:
Start: 04/30/10 End: 05/31/12 Due: 05/31/13

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT01464762 Org: User:
Start: - End: - Due: -

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-63623872 in Healthy Japanese Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT02418559 Org: User:
Start: 05/31/15 End: 07/31/15 Due: 07/31/16

A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT01600963 Org: User:
Start: 03/31/14 End: 11/30/22 Due: 11/30/23

A Study to Assess Safety and Pharmacokinetics of Telaprevir in Patients With Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01600976 Org: User:
Start: 06/30/12 End: 11/30/12 Due: 11/30/13

A Study to Investigate the Potential Pharmacokinetic Interactions Between Phenytoin or Carbamazepine and Telaprevir

Phase: N/A Priority: Normal
NCT ID: NCT01635829 Org: User:
Start: 05/31/12 End: 09/30/12 Due: 09/30/13

A Study to Assess the Drug-Drug Interaction Between VX-787 and Oseltamivir

Phase: N/A Priority: Normal
NCT ID: NCT02262715 Org: User:
Start: 07/31/14 End: 10/31/14 Due: 10/31/15